National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

adefovir dipivoxil
An acyclic nucleotide adenine analogue with potent antiviral activity. Adefovir is activated in vivo to a diphosphate metabolite which is incorporated into viral DNA, leading to viral RNA-dependent DNA polymerase inhibition, DNA chain termination and impairment of viral replication. This agent inhibits the reverse transcriptases of hepatitis B, herpes and HIV viruses, induces natural killer cell activity, and stimulates endogenous interferon production. Viral resistance to adefovir develops at a slower rate compared to other antivirals. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Hepsera
Code name:GS-0840



Previous:Ad5CMV-p53 gene, Ad5F35-LMP1/LMP2-transduced autologous dendritic cells, Adanon, Adderall, Adderall XR
Next:adenovector encoding MDA7, adenoviral vector encoding HSV thymidine kinase, adenovirus 5-tumor necrosis factor alpha, adenovirus B7-1, adenovirus encoding human aquaporin-1

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov